• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ta and T1 bladder cancer: location, recurrence and progression.

作者信息

Heney N M, Nocks B N, Daly J J, Prout G R, Newall J B, Griffin P P, Perrone T L, Szyfelbein W A

出版信息

Br J Urol. 1982 Apr;54(2):152-7. doi: 10.1111/j.1464-410x.1982.tb13538.x.

DOI:10.1111/j.1464-410x.1982.tb13538.x
PMID:7082932
Abstract

An analysis of 58 patients who presented with their first superficial bladder tumour(s) stage Ta or T1 and who were followed prospectively is presented. Tumour characteristics which correlated well with the likelihood of new tumour occurrence were invasion of lamina propria, multiplicity, size equal to or greater than 3 cm and abnormal selected mucosal biopsies. Positive urinary cytology and higher grade tumours correlated, though less strongly. Development of higher grade or stage in subsequent tumours (i.e. progression) was associated with initial tumour multiplicity. While initial tumours were rarely found on the dome (5.2%), new tumour occurrences involved the dome in 29% of patients.

摘要

相似文献

1
Ta and T1 bladder cancer: location, recurrence and progression.
Br J Urol. 1982 Apr;54(2):152-7. doi: 10.1111/j.1464-410x.1982.tb13538.x.
2
Multiple mucosal biopsies and postoperative urinary cytology in patients with bladder cancer.
Eur Urol. 1990;17(4):281-5. doi: 10.1159/000480134.
3
Prognostic significance of biopsy results of normal-looking mucosa in cases of superficial bladder cancer.浅表性膀胱癌病例中外观正常黏膜活检结果的预后意义。
Br J Urol. 1983 Dec;55(6):665-9. doi: 10.1111/j.1464-410x.1983.tb03400.x.
4
Value of random mucosal biopsies in the management of superficial bladder cancer.
Eur Urol. 1992;22(4):288-93. doi: 10.1159/000474774.
5
Tumour location adjacent to the ureteric orifice in primary Ta/T1 bladder cancer is predictive of recurrence.原发性Ta/T1期膀胱癌中肿瘤位置邻近输尿管口可预测复发。
Scand J Urol. 2016;50(1):33-8. doi: 10.3109/21681805.2015.1066849. Epub 2015 Jul 23.
6
Comparative differences between T1a/b and T1e/m as substages in T1 urothelial carcinoma of the bladder.T1a/b 和 T1e/m 作为膀胱尿路上皮癌 T1 亚分期的比较差异。
Int Braz J Urol. 2018 Mar-Apr;44(2):267-272. doi: 10.1590/S1677-5538.IBJU.2017.0424.
7
Bladder wash cytology at diagnosis of Ta-T1 bladder cancer is predictive for recurrence and progression.在诊断 Ta-T1 膀胱癌时进行膀胱冲洗细胞学检查可预测复发和进展。
Urology. 2012 Sep;80(3):625-31. doi: 10.1016/j.urology.2012.04.049.
8
Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.pTa/pT1期膀胱癌患者局部复发的危险因素。
Scand J Urol Nephrol. 2008;42(5):417-21. doi: 10.1080/00365590802016302.
9
The influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancer.固有层浸润程度及p53核积聚发生率对T1期移行细胞膀胱癌患者生存率的影响。
J Urol. 1998 Jan;159(1):91-4. doi: 10.1016/s0022-5347(01)64021-7.
10
Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up.膀胱癌的复发、进展及生存情况。对232例随访时间≥5年的患者进行回顾性分析。
Scand J Urol Nephrol. 1987;21(3):185-95. doi: 10.3109/00365598709180320.

引用本文的文献

1
Best practice in the treatment of nonmuscle invasive bladder cancer.非肌肉浸润性膀胱癌的治疗最佳实践。
Ther Adv Urol. 2012 Feb;4(1):13-32. doi: 10.1177/1756287211431976.
2
Prognostic significance of tumor location in high-grade non-muscle-invasive bladder cancer.高级别非肌肉浸润性膀胱癌肿瘤位置的预后意义。
Med Oncol. 2012 Sep;29(3):1916-20. doi: 10.1007/s12032-011-9999-4. Epub 2011 Jun 9.
3
Racial differences in treatment and outcomes among patients with early stage bladder cancer.早期膀胱癌患者治疗和结局的种族差异。
Cancer. 2010 Jan 1;116(1):50-6. doi: 10.1002/cncr.24701.
4
Provider treatment intensity and outcomes for patients with early-stage bladder cancer.早期膀胱癌患者的医疗服务提供者治疗强度与治疗结果
J Natl Cancer Inst. 2009 Apr 15;101(8):571-80. doi: 10.1093/jnci/djp039. Epub 2009 Apr 7.
5
Epidermal growth factor receptor and bladder cancer.表皮生长因子受体与膀胱癌
Postgrad Med J. 2002 Oct;78(924):584-9. doi: 10.1136/pmj.78.924.584.
6
Current problems and needs in the treatment of pT1 G3 bladder carcinoma.pT1 G3期膀胱癌治疗中的当前问题与需求
Int Urol Nephrol. 2002;33(1):29-40. doi: 10.1023/a:1014492517088.
7
Prognostic utility of human complement factor H related protein test (the BTA stat Test).人补体因子H相关蛋白检测(BTA stat检测)的预后效用
Br J Cancer. 2001 Aug 17;85(4):552-6. doi: 10.1054/bjoc.2001.1938.
8
Correlation of nuclear p53 over-expression with clinical and histopathological features of transitional cell bladder cancer.细胞核p53过表达与移行细胞膀胱癌临床及组织病理学特征的相关性
Int Urol Nephrol. 1997;29(1):25-31. doi: 10.1007/BF02551413.
9
Expression and prognostic value of proliferating cell nuclear antigen in transitional cell carcinoma of the urinary bladder.增殖细胞核抗原在膀胱移行细胞癌中的表达及预后价值
Urol Res. 1997;25(1):25-30. doi: 10.1007/BF00941902.
10
Evaluation of a low-dose intravesical bacillus Calmette-Guérin (Tokyo strain) therapy for superficial bladder cancer.低剂量膀胱内卡介苗(东京株)治疗浅表性膀胱癌的评估
Int Urol Nephrol. 1995;27(6):723-33. doi: 10.1007/BF02552138.